Search result for 'gerd'

India's R&D investment as a percentage of GDP remains low compared to China and the US, with private sector contribution also lagging, according to the Economic Survey 2023-24.

Zydus Lifesciences has signed a licensing deal with Takeda to market Vonoprazan, a P-CAB drug for GERD, in India under the brand name Vault.

Sun Pharma has partnered with Takeda to bring Vonoprazan, a novel gastrointestinal drug, to the Indian market. This partnership aims to provide patients with a new treatment option for reflux...

Wadhwani Foundation partners with AICTE, IITs, and other institutions to establish innovation hubs across India, accelerating commercialization of academic innovations and fostering collaborations.

Akums Drugs & Pharmaceuticals launches a new combination drug for gastrointestinal tract disorders, Rabeprazole and Levosulpiride SR capsules, following DCGI approval.

Torrent Pharmaceuticals has licensed Vonoprazan, a novel P-CAB for GERD treatment, from Takeda. The drug will be marketed in India under the brand name Kabvie.

Strides Pharma Science's unit receives USFDA approval to market a generic version of Sucralfate Oral Suspension, a medication used to treat gastrointestinal diseases.

IESA urges 10-year tax holiday for standalone battery energy storage projects using renewables, reduced GST, and increased PLI scheme capacity in India's 2024 budget.

India Energy Storage Alliance (IESA) calls for a 10-year tax holiday and other incentives for standalone battery energy storage using renewables, aiming to boost the industry.

Granules India receives USFDA approval for generic pantoprazole sodium delayed-release tablets for treating erosive esophagitis associated with GERD.